Cargando…
Colorectal cancer chemoprevention: is aspirin still in the game?
Screening strategies have demonstrated their potential for decreasing the incidence and mortality of cancers, particularly that of colorectal cancer (CRC). Another strategy that has been developed to reduce CRC occurrence is the use of chemoprevention agents. Among them, aspirin is the most promisin...
Autores principales: | Grancher, Adrien, Michel, Pierre, Di Fiore, Frederic, Sefrioui, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9341367/ https://www.ncbi.nlm.nih.gov/pubmed/35905195 http://dx.doi.org/10.1080/15384047.2022.2104561 |
Ejemplares similares
-
Aspirin‐based chemoprevention of colorectal cancer: The role for gut microbiota
por: Diao, Feiyu, et al.
Publicado: (2020) -
Chemoprevention by aspirin against inflammation-related colorectal cancer in mice
por: Ohnishi, Shiho, et al.
Publicado: (2021) -
Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancer
por: Grancher, Adrien, et al.
Publicado: (2022) -
Effects of Aspirin or Clopidogrel on Colorectal Cancer Chemoprevention in Patients with Type 2 Diabetes Mellitus
por: Kuan, Yi-Chun, et al.
Publicado: (2019) -
Gastroprotective [6]-Gingerol Aspirinate as a Novel Chemopreventive Prodrug of Aspirin for Colon Cancer
por: Zhu, Yingdong, et al.
Publicado: (2017)